Literature DB >> 22773248

Effect of continuous positive airway pressure on hemoglobin A(1c) in patients with obstructive sleep apnea: a systematic review and meta-analysis.

Imran H Iftikhar1, Robert P Blankfield.   

Abstract

BACKGROUND: There is little conclusive data regarding the effect of continuous positive airway pressure (CPAP) on glycated hemoglobin (HbA(1c)). An earlier meta-analysis included two randomized controlled trials (RCTs) and found no significant effect of CPAP on HbA(1c). The meta-analysis presented here was conducted to include all relevant observational studies and RCTs on the effect of CPAP on HbA(1c).
METHODS: We searched the PubMed database for all studies published prior to March 2012 for trials of the effect of CPAP on HbA(1c). Data from observational studies and RCTs that met the inclusion criteria were extracted for pre- and post-treatment HbA(1c).
RESULTS: A total of nine studies that included 151 subjects met the inclusion criteria. The duration of the studies ranged from 41 days to 6 months. The mean net change in the HbA(1c) was -0.06 % [95 % CI: -0.24, 0.12] (p = 0.5). Five of the nine studies, with a total of 112 subjects, comprised patients with diabetes mellitus (DM) type 2. The mean net change in HbA(1c) for the subjects with DM type 2 was 0.08 % [95 % CI: -0.26, 0.42] (p = 0.65). The mean net change in HbA(1c) for subjects with DM type 2 in studies that were at least 3 months in duration was 0.16 % [95 % CI: -0.26, 0.58] (p = 0.45).
CONCLUSIONS: This meta-analysis found that CPAP does not reduce HbA(1c) levels when used in the short term.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773248     DOI: 10.1007/s00408-012-9404-x

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  30 in total

1.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Authors:  Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

2.  Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients.

Authors:  Mora Murri; José Alcázar-Ramírez; Lourdes Garrido-Sánchez; Francisco Linde; Juan Alcaide; Fernando Cardona; Francisco J Tinahones
Journal:  Transl Res       Date:  2009-06-27       Impact factor: 7.012

3.  Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment.

Authors:  Isaac Shpirer; Micha J Rapoport; David Stav; Arnon Elizur
Journal:  Sleep Breath       Date:  2011-05-11       Impact factor: 2.816

4.  CPAP treatment of a population-based sample--what are the benefits and the treatment compliance?

Authors:  Eva Lindberg; Christian Berne; Ahmed Elmasry; Jan Hedner; Christer Janson
Journal:  Sleep Med       Date:  2006-06-05       Impact factor: 3.492

5.  Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes.

Authors:  Renee S Aronsohn; Harry Whitmore; Eve Van Cauter; Esra Tasali
Journal:  Am J Respir Crit Care Med       Date:  2009-12-17       Impact factor: 21.405

6.  Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea.

Authors:  Patricia K Nguyen; Chandra K Katikireddy; Michael V McConnell; Clete Kushida; Phillip C Yang
Journal:  J Cardiovasc Magn Reson       Date:  2010-09-03       Impact factor: 5.364

7.  The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes.

Authors:  Igor Alexander Harsch; Simin Pour Schahin; Kerstin Brückner; Martin Radespiel-Tröger; Florian S Fuchs; Eckhart Georg Hahn; Peter Christopher Konturek; Tobias Lohmann; Joachim Hans Ficker
Journal:  Respiration       Date:  2004 May-Jun       Impact factor: 3.580

8.  CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep.

Authors:  Arthur Dawson; Susan L Abel; Richard T Loving; George Dailey; Farhad F Shadan; John W Cronin; Daniel F Kripke; Lawrence E Kline
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

Review 9.  Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis.

Authors:  Lars Hecht; Ralph Möhler; Gabriele Meyer
Journal:  Ger Med Sci       Date:  2011-08-08

10.  HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men.

Authors:  Nikolaos Papanas; Paschalis Steiropoulos; Evangelia Nena; Argyris Tzouvelekis; Efstratios Maltezos; Georgia Trakada; Demosthenes Bouros
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more
  7 in total

1.  CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure.

Authors:  Jamie Chung Mei Lam; Agnes Yuen Kwan Lai; Terence Chi Chun Tam; Michele Mae Ann Yuen; Karen Siu Ling Lam; Mary Sau Man Ip
Journal:  Sleep Breath       Date:  2016-11-05       Impact factor: 2.816

Review 2.  What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?

Authors:  Ivan Guerra de Araújo Freitas; Pedro Felipe Carvalhedo de Bruin; Lia Bittencourt; Veralice Meireles Sales de Bruin; Sérgio Tufik
Journal:  Sleep Breath       Date:  2015-02-26       Impact factor: 2.816

3.  The Veterans Affairs Continuous Positive Airway Pressure Use and Diabetic Retinopathy Study.

Authors:  James Patrick Smith; Luke G Cyr; Laura K Dowd; Kyla S Duchin; Priscilla A Lenihan; Jennifer Sprague
Journal:  Optom Vis Sci       Date:  2019-11       Impact factor: 1.973

Review 4.  Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis.

Authors:  Ye Feng; Zhe Zhang; Zhou-zhou Dong
Journal:  NPJ Prim Care Respir Med       Date:  2015-02-26       Impact factor: 2.871

Review 5.  Effects of continuous positive airway pressure treatment on glycaemic control and insulin sensitivity in patients with obstructive sleep apnoea and type 2 diabetes: a meta-analysis.

Authors:  Liang Chen; Jian-Hao Pei; Hong-Mei Chen
Journal:  Arch Med Sci       Date:  2014-08-29       Impact factor: 3.318

6.  Long-Term Weight Change and Glycemic Control in Patients With Type 2 Diabetes Mellitus and Treated vs. Untreated Sleep-Disordered Breathing-Analysis From the DIAbetes COhoRtE.

Authors:  Louisa Schaller; Michael Arzt; Bettina Jung; Carsten A Böger; Iris M Heid; Stefan Stadler
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

Review 7.  Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.

Authors:  Konstantinos Archontogeorgis; Evangelia Nena; Nikolaos Papanas; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2014-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.